FINAL RESULTS OF A PHASE I-II STUDY ON THE COMBINATION OF PEGYLATED LIPOSOMAL DOXORUBICIN AND WEEKLY DOCETAXEL IN ADVANCED BREAST CANCER


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles